<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04062786</url>
  </required_header>
  <id_info>
    <org_study_id>7294</org_study_id>
    <nct_id>NCT04062786</nct_id>
  </id_info>
  <brief_title>Postoperative Renal Failure in Cardiac Surgery PMSF-PVC Gradient Study</brief_title>
  <acronym>PMSF-PVC</acronym>
  <official_title>Postoperative Renal Failure in Cardiac Surgery PMSF-PVC Gradient Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute renal failure is a frequent and severe postoperative complication of cardiac surgery&#xD;
      performed under extracorporeal circulation.&#xD;
&#xD;
      It is an independent risk factor for mortality and significantly increases the length of&#xD;
      hospital stay.&#xD;
&#xD;
      The origin of renal insufficiency after extracorporeal circulation is multifactorial (long&#xD;
      duration of extracorporeal circulation, hemodynamic instability per and post-extracorporeal&#xD;
      circulation, prolonged hypotension, transfusion ...).&#xD;
&#xD;
      Nevertheless, an entirely different pathophysiological mechanism, though not recent, is less&#xD;
      often mentioned but shows renewed interest. This is the concept of renal venous congestion&#xD;
      which may be responsible for impaired renal function in the absence of cardiac dysfunction.&#xD;
      Based on Guyton's circulatory model, the investigators approach this systemic venous&#xD;
      hypertension through the measurement of the Pmsf-PVC gradient.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 21, 2019</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Actual">February 21, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of the gradient Pmsf (arm) -PVC</measure>
    <time_frame>24 hours</time_frame>
    <description>Monitor the evolution of the Pmsf (arm) -PVC gradient at H24 and compare this gradient between the two patient populations (with and without postoperative acute renal failure)</description>
  </primary_outcome>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Scheduled Heart Surgery</condition>
  <condition>Valve Replacement</condition>
  <condition>Coronary Artery Bypass</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pmsf-PVC gradient measurement</intervention_name>
    <description>implementation of standard standard hemodynamic monitorin</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Major patient with scheduled heart surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age&gt; 18 years&#xD;
&#xD;
          -  subject having signed an informed consent&#xD;
&#xD;
          -  scheduled heart surgery:&#xD;
&#xD;
               -  Valve replacement&#xD;
&#xD;
               -  Coronary artery bypass&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any urgent surgery or redux&#xD;
&#xD;
          -  Severe preoperative chronic renal failure (stage III) defined by GFR &lt;30ml / min&#xD;
&#xD;
          -  Existence of rhythm disorders (permanent ACFA) or serious cardiac conduction&#xD;
             disorders, patients with Pacemaker&#xD;
&#xD;
          -  Preoperative alteration of left ventricular ejection fraction with LVEF &lt;40%&#xD;
&#xD;
          -  Major haemodynamic instability with refractory shock defined by dobutamine ≥10μg / kg&#xD;
             / min and / or norepinephrine ≥ 1μg / kg / min and / or epinephrine ≥ 0.2μg / kg /&#xD;
             min.&#xD;
&#xD;
          -  Intra-aortic versus assisted pelvic balloon&#xD;
&#xD;
          -  Contraindication to femoral arterial catheterization&#xD;
&#xD;
          -  Subject under the protection of justice, subject under guardianship or under tutorship&#xD;
&#xD;
          -  Impossibility of giving the subject informed information (subject in emergency&#xD;
             situation, difficulties in understanding the subject)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bob HEGER</last_name>
      <phone>+33 03 69 55 04 44</phone>
      <email>Bob.heger@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Bob HEGER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Michel MERTES</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annick STEIB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier COLLANGE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel KINDO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gharib AJOB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mircea CRISTINAR</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine MARGUERITE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Walid OULEHRI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François LEVY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François FISCHER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 11, 2019</study_first_submitted>
  <study_first_submitted_qc>August 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2019</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

